medigraphic.com
ISSN 1405-8871 (Print)

2018, Number 4

<< Back Next >>

Aten Fam 2018; 25 (4)

Infectious Viral Mumps: Review, Epidemiological Panorama and Challenges

D�az CFG

Language: Spanish
References: 27
Page: 162-168
PDF size: 369.14 Kb.


ABSTRACT

The mumps virus (MuV) is the etiologic agent of benign viral mumps, it is transmitted by respiratory drops, incubates from 12 to 25 days, the symptoms are presented 16 to 18 days after exposure and the main organ affected are the parotids glands in which local and intense inflammation occurs. The most severe complication is orchitis, which is presented in post-pubertal men. Serology is the simplest method for confirming MuV infection and enzyme immunoassay is the most commonly used test. This disease has no specific treatment; specific prevention is the vaccine, which is composed of live attenuated viruses of the Jeryl Lynn strain and has an efficacy of 88%. Since 2012, increases in the number of mumps cases, incidence, number of bouts, and the proportion of cases associated with outbreaks have been reported, so it is described, in broad terms, infectious viral mumps, its situation in the world, in Mexico, and vaccination challenges.


REFERENCES

  1. Centers for Disease Control and Prevention. Mumps. In Hamborsky J KAWSe, editor. Epidemiology and Prevention of Vaccine-Preventable Diseases. Washington D.C.: Public Health Foundation; 2015; 247-260.

  2. Murray, Patrick R, Ken S. Rosenthal, and Michael A. Pfaller. Paramixovirus. In Murray prksr. Medical Microbiology. Philadelphia: Elsevier/Saunders; 2013; 604-606.

  3. who. Mumps: who position paper. Weekly epidemiological record. 2007;16(7):33-34.

  4. Cui A, Zhu Z, Hu Y, et al. Mumps Epidemiology and Mumps Virus Genotypes Circulating in Mainland China during 2013-2015. PLoS ONE. 2017. Doi: https://doi.org/10.1371/journal. pone.0169561

  5. Jin L, �rvell C, Myers R, Rota PA, Nakayama T, Forcic D, Hiebert J, Brown KE. Genomic diversity of mumps virus and global distribution of the 12 genotypes. Rev Med Virol. 2015;25(2): 85-101.

  6. Magurano F, Baggieri M, Marchi A, Bucci P, Rezza G, Nicoletti L. Mumps clinical diagnostic uncertainty. Eur J Public Health. 2018;28(1):119-123.

  7. Ramanathan R, Voigt EA, Kennedy RB, Poland GA. Knowledge gaps persist and hinder progress in eliminating mumps. Vaccine. 2018;36(26):3721- 3726. Doi: 10.1016/j.vaccine.2018.05.067.

  8. Hviid A, Rubin S, M�hlemann K. Mumps. Lancet. 2008;15(971(9616)):932-44.

  9. Taparelli F, Squadrini F, De Rienzo B, Lami G, Fornaciari A. Isolation of mumps virus from vaginal secretions in association with oophoritis. J Infect. 1988 Nov; 17(3):255-8.

  10. Vaidya SR, Chowdhury DT, Jadhav SM, Hamde VS. Complete genome sequence of mumps viruses isolated from patients with parotitis, pancreatitis and encephalitis in India. Infect Genet Evol. 2016;39:272-78.

  11. cdc. Brief report: update: mumps activity. United States, January 1-October 7, 2006. MMWR Morb Mortal Wkly Rep. 2006;(55):1152-53.

  12. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580-89.

  13. Secretar�a de Salud. Direcci�n General de Epidemiolog�a. Lineamientos para la vigilancia epidemiol�gica de la enfermedad febril exantem�tica por laboratorio. [Internet] 2015 [Citado 2018 Jun 12]. Disponible en: https://www. gob.mx/cms/uploads/attachment/file/159097/ Lineamientos_para_la_vigilancia_epidemiologica_ de_enfermedad_febril_exantematica.pdf

  14. Yang Q, Yang Z, Ding H, et al. The relationship between meteorological factors and mumps incidence in Guangzhou, China, 2005-2012: A distributed lag nonlinear time-series analysis. Human Vaccines & Immunotherapeutics. 2014;10(8):2421-32.

  15. Latner DR, Hickman CJ (2015) Remembering Mumps. PLoS Pathog 11(5): e1004791. https:// doi.org/10.1371/journal.ppat.1004791

  16. Organizaci�n Mundial de la Salud. Incidencia de Enfermedades Prevenibles por Vacunaci�n. [Internet] 2018 [Citado 2018 Julio 2] Disponible en: http://apps.who.int/immunization_monitoring/ globalsummary/timeseries/tsincidencemumps.html

  17. Marin M. Update on mumps epidemiology, United States. Atlanta, GA: CDC, Presentation at the Advisory Committee on Immunization Practices meeting; 2017.

  18. Diario Oficial de la Federaci�n. Secretar�a de Salud. Norma Oficial Mexicana nom-017-SSA2-2012, Para la vigilancia epidemiol�gica. [Internet] 2013 [Citado 2018 Jun 26] Disponible en: http://dof. gob.mx/nota_detalle.php?codigo=5288225&fec ha=19/02/2013.

  19. Secretar�a de Salud. Direcci�n General de Epidemiolog�a. Sistema Nacional de Vigilancia Epidemiol�gica. Informaci�n Epidemiol�gica. [Internet] 2008-2018 [Citado 2018 Jun 28] Disponible en: https://www.gob.mx/salud/accionesy- programas/informacion-epidemiologica

  20. Bockelman C, Frawley TC, Long B, Koyfman A. Mumps: An Emergency Medicine-Focused Update. J Emerg Med. 2018;54(2):207-214.

  21. Secretar�a de Salud - CENSIA. Lineamientos Generales del Programa de Vacunaci�n Universal y Semanas Nacionales de Salud 2018. [Internet] 2017 [Citado 2018 Jul 19] Disponible en: https://www. gob.mx/cms/uploads/attachment/file/294272/ Lineamientos_PVU_y_SNS_2018_corregidos.pdf

  22. Marin M, Marlow M, Moore KL, Patel M. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus�Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak. mmwr Morb Mortal Wkly Rep. 2018;67(1):33-38.

  23. M�ndez-Herrera A, Arias-Toledo E, S�nchez-Alem�n M, Olamendi-Portugal ML, Ruiz-G�mez J, D�az-Ortega JL. Antibody prevalence to mumps in children and adolescents at two years of the introduction of the MMR vaccine. Salud Publica Mex. 2018;Jan-Feb;60(1):p.71-76.

  24. May M, Rieder CA, Rowe RJ. Emergent lineages of mumps virus suggest the need for a polyvalent vaccine. Int J Infect Dis. 2018;Jan;66:p.1-4.

  25. Ma C, Liu Y, Tang J, Jia H, Qin W, Su Y, Wang H, Hao L. Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China. Hum Vaccin Immunother. 2018 Jun;14(6):p.1392-97.

  26. Principi N, Esposito S. Mumps outbreaks: A problem in need of solutions. J Infect. 2018 Jun;76(6):503-6.

  27. Plotkin SA. Mumps: A Pain in the Neck. J Pediatric Infect Dis Soc. 2018 May; 7(2):91-92.




2020     |     www.medigraphic.com

OSZAR »